Collectively, these data suggested that etoposide inhibits PD-L1 expression of both CSC and non-CSC populations and attenuates the tumor-initiating ability and cancer cell-mediated immunosuppressive activity of CSCs. The gene discussed is CD274; the disease is neoplasm.